2026-01-24 - Analysis Report
**Company Overview**
Estée Lauder is a multinational manufacturer and marketer of a wide range of skin care, hair care, and fragrance products.

**Return Rate Comparison**

|  | Cumulative Return | Divergence |
| --- | --- | --- |
| EL (Estée Lauder) | -5.26% | -131.70 (Relative Divergence: 11.10%) |
| VOO (S&P 500) | 126.41% |  |

The stock's cumulative return is significantly lower than that of the S&P 500. The divergence is 131.70, indicating a notable difference in performance.

**Alpha, Beta Analysis**

| Year | CAGR | MDD | Alpha | Beta | Cap(B) |
| --- | --- | --- | --- | --- | --- |
| 2016-2018 | 30.0% | 19.8% | 18.0% | 0.8 | 46.9B |
| 2017-2019 | 92.0% | 19.8% | 67.0% | 0.9 | 74.4B |
| 2018-2020 | 72.0% | 32.6% | 47.0% | 0.9 | 95.9B |
| 2019-2021 | 143.0% | 32.6% | 77.0% | 1.0 | 133.4B |
| 2020-2022 | 1.0% | 44.9% | -6.0% | 1.1 | 89.4B |
| 2021-2023 | -91.0% | 66.0% | -112.0% | 1.3 | 52.7B |
| 2022-2024 | -176.0% | 72.1% | -205.0% | 1.3 | 27.0B |
| 2023-2025 | -110.0% | 74.6% | -185.0% | 1.3 | 37.7B |

**Recent Stock Price Fluctuations**

|  | Price |
| --- | --- |
| Close | $117.69 |
| Last-Market | $117.69 / $119.49 (change: -1.51) |
| 5-day SMA | $116.91 |
| 20-day SMA | $111.53 |
| 60-day SMA | $101.75 |

**RSI, PPO Index Indicators and Delta_Previous_Relative_Divergence**

* Market Risk Indicator (MRI): 0.70
* RSI: 69.94
* PPO: 0.24
* Hybrid Signal: Buy (Cash 0%)
* Risk Level: Medium (MRI 0.70)
* Recent (20 days) relative divergence change: 1.10 (+): improving
* 7-day Rank change: 135 (+): rank up
* 7-day Dynamic Expected Return change: 194.30 (+): improving
* If 'previousClose': 119.49 is large, reflect the fluctuation issue (sharp rebound, sharp decline).
* Expected Return (%): -579.60%, Expected excess return compared to S&P 500 if invested long-term (more than 2 years) from this point.

**Recent News & Significant Events**

[2026-01-22] Is The Estee Lauder Companies (EL) Outperforming Other Consumer Staples Stocks This Year? 
[2026-01-21] Estee Lauder Companies (NYSE:EL) Stock Price Expected to Rise, TD Cowen Analyst Says 
[2026-01-21] Assessing Estée Lauder (EL) Valuation After Recent Share Price Momentum And Premium P/S Multiple 
[2026-01-23] Kimberly-Clark's Q4 Earnings Coming Up: What Investors Need to Know 
[2026-01-09] Is Estee Lauder (EL) a Good Stock to Buy? 
[2026-01-21] Estee Lauder (EL): TD Cowen Raises Price Target to $130 | EL Stock Analysis Update 

**Analyst Opinions**

Analyst Consensus:
- Key: Buy
- Mean (1=StrongBuy~5=Sell): 2.42 (~Buy)
- Opinions: 24
- Target Price (avg/high/low): 109.58 / 131.00 / 65.00

**Recent Earnings Analysis**

| Date | EPS | Revenue |
| --- | --- | --- |
| 2025-10-30 | 0.13 | 3.48 B$ |
| 2025-05-01 | 0.44 | 3.55 B$ |
| 2025-02-04 | -1.64 | 4.00 B$ |
| 2024-10-31 | -0.43 | 3.36 B$ |

The stock has experienced a range of profit margins, from 72.00% to 76.10%. EPS has been volatile, with a high of 0.44 and a low of -1.64.

**Revenue and Profitability**

| Quarter | Revenue | Profit Margin |
| --- | --- | --- |
| 2025-09-30 | $3.48B | 73.37% |
| 2025-06-30 | $3.41B | 72.00% |
| 2025-03-31 | $3.55B | 74.96% |
| 2024-12-31 | $4.00B | 76.10% |
| 2024-09-30 | $3.36B | 72.39% |

**Capital and Profitability**

| Quarter | Equity | ROE |
| --- | --- | --- |
| 2025-09-30 | $3.89B | 1.21% |
| 2025-06-30 | $3.87B | -14.13% |
| 2025-03-31 | $4.34B | 3.66% |
| 2024-12-31 | $4.17B | -14.15% |
| 2024-09-30 | $5.08B | -3.07% |

**Comprehensive Analysis (Summary of previous items)**

The stock's recent performance has been divergent from the S&P 500, and its cumulative return is significantly lower. Earnings analysis shows a volatile range of profit margins and EPS. Market risk indicators suggest a medium risk level, and recent news and significant events indicate analyst sentiment remains neutral. Equity and ROE show fluctuations, with a decline in ROE in the second quarter of 2025.

**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.